Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuya Karaki

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2022
Lysophospholipids-potent candidates for brain food, protects neuronal cells against α-Synuclein aggregationTatsuya Karaki, Hisao Haniu, Yoshikazu Matsuda, et al.
Biomedicines|December 23, 2022
Lysophospholipids: A Potential Drug Candidates for Neurodegenerative DisordersTatsuya Karaki, Hisao Haniu, Yoshikazu Matsuda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Inflammatory mediators of mRNA vaccine-induced adverse reactions in miceKoyo Honda, Tatsuya Karaki, Yuta Kunishima, et al.
ACS Nano|July 23, 2025
Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component OptimizationYoshino Kawaguchi, Mari Kimura, Tatsuya Karaki, et al.
Molecular Therapy. Nucleic Acids|June 15, 2026
Comparative immunogenic and structural analysis of virus-like particle and inactivated whole-virion vaccines against enterovirus D68Kota Senpuku, Yuta Kunishima, Mika Hirose, et al.
Protein Science : a Publication of the Protein Society|September 13, 2025
Rational design of a covalent ACE2 decoy receptor that broadly neutralizes SARS-CoV-2 variantsNobumasa Hino, Risa Takada, Kyosuke Suzuki, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 20, 2022
Lysophospholipids-potent candidates for brain food, protects neuronal cells against α-Synuclein aggregationTatsuya Karaki, Hisao Haniu, Yoshikazu Matsuda, et al.
Biomedicines|December 23, 2022
Lysophospholipids: A Potential Drug Candidates for Neurodegenerative DisordersTatsuya Karaki, Hisao Haniu, Yoshikazu Matsuda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Inflammatory mediators of mRNA vaccine-induced adverse reactions in miceKoyo Honda, Tatsuya Karaki, Yuta Kunishima, et al.
ACS Nano|July 23, 2025
Modulating Immunogenicity and Reactogenicity in mRNA-Lipid Nanoparticle Vaccines through Lipid Component OptimizationYoshino Kawaguchi, Mari Kimura, Tatsuya Karaki, et al.
Molecular Therapy. Nucleic Acids|June 15, 2026
Comparative immunogenic and structural analysis of virus-like particle and inactivated whole-virion vaccines against enterovirus D68Kota Senpuku, Yuta Kunishima, Mika Hirose, et al.
Protein Science : a Publication of the Protein Society|September 13, 2025
Rational design of a covalent ACE2 decoy receptor that broadly neutralizes SARS-CoV-2 variantsNobumasa Hino, Risa Takada, Kyosuke Suzuki, et al.
Pageof 1